Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
British Journal of Cancer
|
July 29, 2017
A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories
Gillian Ellison, Andrew Wallace, Alexander Kohlmann, et al.
Journal of Clinical Pathology
|
November 23, 2012
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison, Guanshan Zhu, Alexandros Moulis, et al.
BMC Clinical Pathology
|
April 11, 2015
A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing
Gillian Ellison, Shuwen Huang, Hedley Carr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 8, 2010
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
Gillian Ellison, Emma Donald, Gael McWalter, et al.
Journal of Clinical Pathology
|
July 27, 2013
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu, Yachao Lu, Guanshan Zhu, et al.
The Journal of Molecular Diagnostics : JMD
|
March 18, 2014
Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system
Kyaw L Aung, Emma Donald, Gillian Ellison, et al.
Oncotarget
|
October 30, 2016
Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
Cindy Badoer, Céline Garrec, Dirk Goossens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 11, 2017
The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients
Xiaohua Wu, Lingying Wu, Beihua Kong, et al.
International Journal of Oncology
|
January 17, 2009
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer
Lucy J Knight, Joseph Burrage, Sarah R Bujac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
Fred R Hirsch, Marileila Varella-Garcia, Paul A Bunn, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
British Journal of Cancer
|
July 29, 2017
A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories
Gillian Ellison, Andrew Wallace, Alexander Kohlmann, et al.
Journal of Clinical Pathology
|
November 23, 2012
EGFR mutation testing in lung cancer: a review of available methods and their use for analysis of tumour tissue and cytology samples
Gillian Ellison, Guanshan Zhu, Alexandros Moulis, et al.
BMC Clinical Pathology
|
April 11, 2015
A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing
Gillian Ellison, Shuwen Huang, Hedley Carr, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
October 8, 2010
A comparison of ARMS and DNA sequencing for mutation analysis in clinical biopsy samples
Gillian Ellison, Emma Donald, Gael McWalter, et al.
Journal of Clinical Pathology
|
July 27, 2013
The diagnostic accuracy of pleural effusion and plasma samples versus tumour tissue for detection of EGFR mutation in patients with advanced non-small cell lung cancer: comparison of methodologies
Xiaoqing Liu, Yachao Lu, Guanshan Zhu, et al.
The Journal of Molecular Diagnostics : JMD
|
March 18, 2014
Analytical validation of BRAF mutation testing from circulating free DNA using the amplification refractory mutation testing system
Kyaw L Aung, Emma Donald, Gillian Ellison, et al.
Oncotarget
|
October 30, 2016
Performance of multiplicom's BRCA MASTR Dx kit on the detection of BRCA1 and BRCA2 mutations in fresh frozen ovarian and breast tumor samples
Cindy Badoer, Céline Garrec, Dirk Goossens, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 11, 2017
The First Nationwide Multicenter Prevalence Study of Germline BRCA1 and BRCA2 Mutations in Chinese Ovarian Cancer Patients
Xiaohua Wu, Lingying Wu, Beihua Kong, et al.
International Journal of Oncology
|
January 17, 2009
Epigenetic silencing of the endothelin-B receptor gene in non-small cell lung cancer
Lucy J Knight, Joseph Burrage, Sarah R Bujac, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 2006
Molecular predictors of outcome with gefitinib in a phase III placebo-controlled study in advanced non-small-cell lung cancer
Fred R Hirsch, Marileila Varella-Garcia, Paul A Bunn, et al.
Page
of 2